Ignite Creation Date:
2024-05-05 @ 9:36 AM
Last Modification Date:
2024-10-26 @ 9:02 AM
Study NCT ID:
NCT00001885
Status:
COMPLETED
Last Update Posted:
2017-07-02
First Post:
1999-11-03
Brief Title:
Identification of Genes Associated With Lung Disease in Patients With Rheumatoid Arthritis
Sponsor:
National Heart Lung and Blood Institute NHLBI
Organization:
National Institutes of Health Clinical Center CC
Study Overview
Official Title:
Pulmonary Fibrosis Associated With Rheumatoid Arthritis Identification of Genetic Polymorphisms
Status:
COMPLETED
Status Verified Date:
2007-12-28
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Pulmonary fibrosis PF is a condition in which the lungs of a patient become scarred and fibrous It has been known to occur in as many as 40 of patients diagnosed with rheumatoid arthritis RA The cause of the pulmonary fibrosis in patients with RA is unknown
Data gathered from previous research studies suggest that genetics may play a role in the development of PF in patients with rheumatoid arthritis However the actual genetic factors involved in the disease process have not been identified
The goal of this study is to identify the genetic markers in patients with pulmonary fibrosis and rheumatoid arthritis
Data gathered from previous research studies suggest that genetics may play a role in the development of PF in patients with rheumatoid arthritis However the actual genetic factors involved in the disease process have not been identified
The goal of this study is to identify the genetic markers in patients with pulmonary fibrosis and rheumatoid arthritis
Detailed Description:
Pulmonary fibrosis that develops within a subpopulation of patients with rheumatoid arthritis is a disorder of unknown etiology Although previous reports suggest that some individuals with rheumatoid arthritis have a genetic predisposition to the development of fibrotic lung disease genetic factors have not been clearly identified It is the intent of this clinical protocol to identify genetic polymorphisms in individuals with pulmonary fibrosis and rheumatoid arthritis
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None
Secondary IDs
| Secondary ID | Type | Domain | Link |
|---|---|---|---|
| 99-H-0069 | None | None | None |